OverviewSuggest Edit

Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a biopharmaceutical company innovating women’s reproductive health and pregnancy therapeutics from conception to birth. Between the ages of 20 and 50, millions of women worldwide suffer from reproductive health conditions that affect their quality of life and their ability to conceive or may lead to complications during pregnancy. ObsEva aims to improve upon the current treatment landscape with the development of novel, oral medicines with potentially best-in-class safety and efficacy profiles. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with multiple development programs focused on treating endometriosis, uterine fibroids, and preterm labor. ObsEva is supported by top-tier investors and a globally recognized board and is well-positioned to establish a leadership position in women’s reproductive therapeutics.
TypePrivate
Founded2012
HQPlan-les-Ouates, CH
Websiteobseva.com

Latest Updates

Employees (est.) (Sept 2020)53(-1%)
Cybersecurity ratingAMore

Key People/Management at ObsEva

Jean-Pierre Gotteland

Jean-Pierre Gotteland

Chief Scientific Officer and Head of R&D
James I. Healy

James I. Healy

Director
Tim Adams

Tim Adams

Chief Financial Officer
Fabien de Ladonchamps

Fabien de Ladonchamps

Interim Chief Financial Officer
Wim Souverijns

Wim Souverijns

Chief Commercial Officer
Elizabeth Garner

Elizabeth Garner

Chief Medical Officer
Show more

ObsEva Office Locations

ObsEva has offices in Plan-les-Ouates and Sacramento
Plan-les-Ouates, CH (HQ)
Chemin des Aulx 12
Sacramento, US
400 R St
Show all (2)

ObsEva Financials and Metrics

Summary Metrics

Founding Date

2012

ObsEva total Funding

$92.9 m

ObsEva latest funding size

$60 m

Time since last funding

5 years ago

ObsEva investors

ObsEva's latest funding round in November 2015 was reported to be $60 m. In total, ObsEva has raised $92.9 m
Show all financial metrics

ObsEva Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

ObsEva Online and Social Media Presence

Embed Graph

ObsEva Blogs

ObsEva to participate in Cantor Global Healthcare Conference October 2-4 2019

Click here for the webcast The post ObsEva to participate in Cantor Global Healthcare Conference October 2-4 2019 appeared first on ObsEva.

ObsEva announces new composition of its Executive Committee

Geneva, Switzerland and Boston, MA – September 11, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage... The post ObsEva announces new composition of its Executive Committee appeared first on ObsEva.

ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 13- 14, 2019

Geneva, Switzerland and Boston, MA – August 9, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical... The post ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 13- 14, 2019 appeared first on ObsEva.

ObsEva SA Announces $75 Million Credit Facility with Oxford Finance LLC

Geneva, Switzerland and Boston, MA – August 7, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage... The post ObsEva SA Announces $75 Million Credit Facility with Oxford Finance LLC appeared first on ObsEva.

ObsEva SA to Hold Second Quarter 2019 Financial Results and Business Update Call on August 7, 2019

Geneva, Switzerland and Boston, MA – August 5, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage... The post ObsEva SA to Hold Second Quarter 2019 Financial Results and Business Update Call on August 7, 2019 appeared first on ObsEva.

Work With Us

Are you ready to join an innovative biopharmaceutical company that’s advancing women’s reproductive health and pregnancy therapeutics? Explore our available... The post Work With Us appeared first on ObsEva.
Show more

ObsEva Frequently Asked Questions

  • When was ObsEva founded?

    ObsEva was founded in 2012.

  • Who are ObsEva key executives?

    ObsEva's key executives are Jean-Pierre Gotteland, James I. Healy and Tim Adams.

  • How many employees does ObsEva have?

    ObsEva has 53 employees.

  • Who are ObsEva competitors?

    Competitors of ObsEva include Biofrontera, Recro Gainesville and Skyepharma.

  • Where is ObsEva headquarters?

    ObsEva headquarters is located at Chemin des Aulx 12, Plan-les-Ouates.

  • Where are ObsEva offices?

    ObsEva has offices in Plan-les-Ouates and Sacramento.

  • How many offices does ObsEva have?

    ObsEva has 2 offices.